"Thanks to the Innovation Fund, our donors to the MGH Foundation and the vision of the Max Pacioretty Foundation, this new specialized MRI will place the Montreal General Hospital as one of the leading level 1 trauma centres in Canada. This valuable piece of healthcare technology will also allow our world-class researchers to better understand brain injuries, which will lead to improved patient diagnosis and treatment," adds Jean-Guy Gourdeau, President and Chief Executive Officer of the Montreal General Hospital Foundation at the MUHC.
With 14 million new cases annually, cancer is among the leading causes of morbidity and mortality worldwide. The spread of disease to different organs and the resistance to therapy are current cancer challenges. CFI-funded researcher, Dr. Park and her team, who has been awarded $2,389,840 million, will build cutting-edge technologies to address these challenges in urgent need of solutions and result in new personalized approaches to treat cancer.
"Thanks to this grant, we will use micro-fabrication and novel scaffold materials to recreate the environment of multiple cancers.'' explains says Dr. Park, who is a researcher at the Goodman Cancer Research Centre at McGill University and at the RI-MUHC. "It will help us to enhance discovery of new targets and potential drugs for the tumour ecosystem and not just the tumor."
Link the national release: http://www.innovation.ca/en/AboutUs/News/GovernmentofCanadainvestmentsinstateoftheartresearchfacilitieshelpimproveourqualityoflifeandcreateprosperity
Study highlights long-term risks of prostate cancer treatment